Presented at #ESCCongress:
In older adults without cardiovascular disease, treatment with atorvastatin led to a lower risk of major cardiovascular events than placebo at a median of 5.9 years but did not result in longer disability-free survival. Full STAREE trial results: https://t.co/LLJtTGssg8
@escardio
A new chronic traumatic encephalopathy study won’t change football overnight, writes @PaulSaxMD in a new NEJM Voices blog post, but it may inform the conversation parents have about whether their kids should play it.
Learn more and sign up for email alerts: https://t.co/2FdcFrNWQv
A 46-year-old man with cirrhosis presented to the ED with a 1-week history of left flank pain. He reported no recent trauma, medical procedures, or use of anticoagulant or antiplatelet medications. His heart rate was 128 beats per minute, and his blood pressure was 64/37 mm Hg. Laboratory studies were notable for anemia, severe thrombocytopenia, and findings consistent with advanced liver disease. Physical examination and contrast-enhanced CT of the abdomen are shown. What is the diagnosis? Submit your answer: https://t.co/YVNuOYOYYv
Would treatment with azacitidine–venetoclax improve event-free survival over induction chemotherapy in induction-eligible adults with acute myeloid leukemia? Research findings are summarized in a new Quick Take video. https://t.co/g6wL72tCXG
The authors of a new Perspective argue that clinicians who overlook patients’ relationships with their pets may both miss opportunities to improve health and misinterpret health care decisions that are constrained by competing obligations. Learn more: https://t.co/CsytFXvgA3
Among 16 patients with refractory neurologic autoimmune disorders, lentiviral CD19 CAR T-cell therapy was associated with manageable side effects, complete B-cell depletion, and preliminary clinical improvement across disease groups. Full trial results: https://t.co/tAzWTKs4rm
Consider this your Friday reset reminder. If you haven’t checked out Medlines yet, the routine is easy! Subscribe, hit play on Fridays, get the past week in health care news summarized by @DGlaucomflecken, his fellow anchors, and the Human Content team. Follow: https://t.co/8i7IRDjJ5E
Among patients with previously treated metastatic RAS-mutant NSCLC receiving daraxonrasib at a dose of 300 mg or less daily, 54% had adverse events of grade 3 or higher, and antitumor activity was reported in more than 30%.
Read the abstract here: https://t.co/4XFCWCgIwP
The drug, called daraxonrasib, was approved by the FDA for advanced pancreatic cancer after it was shown to roughly double how long patients lived. https://t.co/RPJ1AOBrCH
𝗣𝗹𝗮𝗰𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗮 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿 𝗳𝗼𝗿 𝗔𝗰𝘂𝘁𝗲 𝗣𝗲𝗿𝗶𝘁𝗼𝗻𝗲𝗮𝗹 𝗗𝗶𝗮𝗹𝘆𝘀𝗶𝘀
Once you are sure that the catheter is in the correct position and drains well, secure it in place using 2-0 synthetic sutures. A purse-string suture will reduce the risk of leakage and catheter migration. Learn more: https://t.co/lP3NN23Fiq
A 62-year-old woman with a history of stroke and metastatic breast cancer that was being treated with immunomodulator therapy presented with memory loss, confabulation, anhedonia, ataxia, and weight loss. What is the most likely diagnosis?
Read the case details and vote: https://t.co/Fh7tYtpgVX
#Neurology
A 46-year-old man with CKD presented with a 2-year history of painless shortening and rounding of the fingertips. Radiographs of the hands showed resorption of the terminal tufts of all the distal phalanges.
Read the full case details in the Images in Clinical Medicine article “Acro-Osteolysis”: https://t.co/GUGeiAZvfe
In a new Perspective, Jensen and colleagues argue that in states with abortion bans, clinicians and hospitals should reduce harm by maximizing care to the extent legally possible, thereby recentering medical expertise and commitment to patient-centered care. Read the full Perspective: https://t.co/h2PS9S0ktN
A 46-year-old woman presented to her primary care physician with a 3-week history of right forefoot pain. The pain had begun spontaneously, worsened with weight bearing, and was not preceded by trauma. 👉 https://t.co/bUxazlBAY6
She reported no joint pain, fever, or other systemic symptoms. Her medical history included hypertension, which was being treated with losartan, and a cesarean section 25 years earlier. She said that she did not participate in high-impact exercise and that she worked as an office manager.
On physical examination, the foot had no wounds, deformities, swelling, or erythema. Palpation over the fourth metatarsal and axial loading of the fourth toe reproduced the pain; mediolateral metatarsal compression did not. The ankle, foot, and toes had full, painless range of motion. Her gait was normal. Neurologic function, arterial pulses, and capillary refill were intact.
Read the full case details and authors’ commentary in the Clinical Problem-Solving feature “Break a Leg” by M. Wijnen et al.: https://t.co/bUxazlBAY6
New in the September 3, 2026, issue of NEJM:
Azacitidine–Venetoclax or Induction for AML (PARADIGM trial) https://t.co/iiDNsw6CUW
Oral Infigratinib in Children with Achondroplasia (PROPEL 3 trial) https://t.co/Ue0ZNDDT5n
Balanced Fluid or 0.9% Saline for Septic Shock (PRoMPT BOLUS trial) https://t.co/nt8SGVMSNW
Daraxonrasib for Previously Treated 𝘙𝘈𝘚-Mutant NSCLC https://t.co/Jhq1M1zwEU
Subscribe to NEJM for the latest medical research: https://t.co/QFe1he2Tzn
A 72-year-old man presented with a 2-month history of a painful lump on his neck. Cytologic analysis of fine-needle aspirate was consistent with suppurative lymphadenopathy. The lesion subsequently ulcerated and released purulent discharge.
Read the full case details in the Images in Clinical Medicine article “Scrofuloderma”: https://t.co/KPfP3m2ZCO
The authors of a new Perspective write that antiabortion advocates have asserted that mifepristone must be prescribed in person to prevent reproductive coercion, specifically forced abortions. But this argument targets the wrong culprit. Read the Perspective by Elizabeth Tobin-Tyler, JD, and Gabriella Chalker, BA: https://t.co/mAECbufFuA
A new Clinical Practice article summarizes the management of pulmonary nodules, with an emphasis on nodule type, imaging follow-up, cancer risk, and strategies to balance timely diagnosis with avoidance of unnecessary procedures.
Read “Pulmonary Nodules” by Matthew E.J. Callister, PhD, and Gerard A. Silvestri, MD: https://t.co/zb8xCMfODs
In a phase 1–2 study of daraxonrasib, 54% of patients with RAS-mutant non–small-cell lung cancer had grade 3 or higher adverse events, mainly pneumonia, diarrhea, and rash; more than 30% of patients had a response. Full study results: https://t.co/4XFCWCgIwP
In a randomized phase 2 trial involving adults with AML, azacitidine–venetoclax led to longer event-free survival than induction chemotherapy, with a lower risk of severe infection and hemorrhage. Full PARADIGM trial results: https://t.co/iiDNsw6CUW
Editorial: Hypomethylating Agents plus Venetoclax as Compared with Intensive Chemotherapy in Patients with AML https://t.co/zsAPQjxEDb
𝐍𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐢𝐧 𝑵𝑬𝑱𝑴 𝑬𝒗𝒊𝒅𝒆𝒏𝒄𝒆!
A new Public Health Alerts report, published in partnership with @CIDRAP: Cyclosporiasis Outbreak in Michigan, May–July 2026 — An Interim Report https://t.co/lhayTmH9p4
#InfectiousDisease
A disproportionate number of hospital-acquired C. diff infections were attributed to a Henry Ford Hospital nephrology unit. Through early detection, interdisciplinary collaboration, and culture change, the unit reduced these infections by 90%. Learn more: https://t.co/fM0T5oAAb7